064550 — Bioneer Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapContrarian

Annual cashflow statement for Bioneer, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	ARS	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	29,199	15,122	-6,919	-19,042	1,707
Depreciation
Amortisation
Non-Cash Items	41,453	6,636	12,005	10,831	16,290
Unusual Items
Purchased R&D
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	-23,332	-21,023	-9,904	-14,393	-16,634
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities	53,175	8,805	4,136	-13,476	10,331
Capital Expenditures	-43,286	-18,524	-4,660	-12,635	-6,786
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-2,338	-625	-8,809	-9,240	-28,496
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Change in Net Intangibles
Other Investing Cash Flow
Cash from Investing Activities	-45,624	-19,149	-13,468	-21,875	-35,281
Financing Cash Flow Items	-8.75	-5.81	-94.8	0	—
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	7,753	4,674	14,055	26,106	32,579
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	16,726	-5,547	4,703	-8,531	7,657